One-Day fix for big liver tumors? new study tests Same-Day radiation

NCT ID NCT06944483

Recruiting now Disease control Sponsor: Seoul National University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether people with large liver cancer (over 5 cm) can get their entire radioembolization treatment in a single day. Normally, planning scans and treatment are done on separate days. The procedure involves injecting tiny radioactive beads into the liver's blood supply to kill cancer cells. Researchers will check if this one-day approach is safe and works well for 138 participants.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Y90 resin microspheres (SIR-Spheres)
What this could lead to: If successful, this could make treatment for large liver tumors more convenient by completing planning and therapy in one day, potentially reducing hospital visits.
What could go wrong: This is an early registry study with only 138 participants, so results may not apply to all patients. There are risks like radiation exposure to the lungs or liver damage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hepatocellular carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEPATOCELLULAR CARCINOMA (HCC)

Contacts and locations

Locations

National Cancer Center
RECRUITING

Goyang, South Korea
Samsung Medical Center
NOT_YET_RECRUITING

Seoul, South Korea
Seoul National University Hospital
RECRUITING

Seoul, South Korea
Severance hospital
NOT_YET_RECRUITING

Seoul, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.